Ticker League

Operating Income for Gilead Sciences (GILD)

Latest filings through · Reported

Metric

TTM

$11.38B

YoY change

+604.0%

5Y CAGR

+23.5%

Peak year (2015)

$22.19B

Operating Income history chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: $11.70B

Operating Income growth chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: +604.0%

Operating Income history table for Gilead Sciences (GILD) from 1990 to 2025

  • 2025$11.70B+604.0%
  • 2024$1.66B-78.1%
  • 2023$7.61B+3.8%
  • 2022$7.33B-26.1%
  • 2021$9.92B+143.6%
  • 2020$4.07B-5.0%
  • 2019$4.29B-47.7%
  • 2018$8.20B-41.9%
  • 2017$14.12B-19.9%
  • 2016$17.63B-20.5%
  • 2015$22.19B+45.4%
  • 2014$15.27B+237.4%
  • 2013$4.52B+12.8%
  • 2012$4.01B+5.8%
  • 2011$3.79B-4.4%
  • 2010$3.96B+12.3%
  • 2009$3.53B+31.8%
  • 2008$2.68B+23.7%
  • 2007$2.16B-385.3%
  • 2006−$758.75M-168.4%
  • 2005$1.11B+76.8%
  • 2004$627.39M-495.4%
  • 2003−$158.68M-295.9%
  • 2002$81.01M-167.1%
  • 2001−$120.69M+130.7%
  • 2000−$52.32M+1.2%
  • 1999−$51.70M-34.0%
  • 1998−$78.30M+8.6%
  • 1997−$72.10M+99.7%
  • 1996−$36.10M+12.8%
  • 1995−$32.00M-9.1%
  • 1994−$35.20M—
  • 1992−$18.20M+188.9%
  • 1991−$6.30M+31.3%
  • 1990−$4.80M—

Operating Income values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Income at Gilead Sciences (GILD)

According to Gilead Sciences's latest reported financial statements, the company's current operating income (TTM) is $11.38B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Gilead Sciences (GILD) operating income is $11.70B – surged 604.0% year-over-year.

Gilead Sciences operating income has grown on net over the period, with a +23.5% compound annual growth rate over 2020–2025 (5 years).

Between 2015 and 2025, Gilead Sciences operating income plunged 47.3%, falling from $22.19B to $11.70B.

The highest annual operating income of $22.19B was reported in 2015. The lowest in the available history was −$758.75M in 2006.

Gilead Sciences Operating Income by Year

Gilead Sciences Operating Income 2025: $11.70B

2025's operating income for Gilead Sciences came in at $11.70B, surged 604.0% from 2024.

Gilead Sciences Operating Income 2024: $1.66B

Gilead Sciences posted operating income of $1.66B in 2024, plunged 78.1% below 2023.

Gilead Sciences Operating Income 2023: $7.61B

In 2023, Gilead Sciences reported operating income of $7.61B, edged up 3.8% from 2022.

Gilead Sciences Operating Income 2022: $7.33B

Gilead Sciences operating income in 2022 was $7.33B, declined 26.1% below 2021.

Gilead Sciences Operating Income 2021: $9.92B

Gilead Sciences operating income in 2021 was $9.92B.

See more financial history for Gilead Sciences (GILD).

Sector peers by Operating Income

Healthcare peers of Gilead Sciences (GILD), ranked by their latest operating income

Frequently asked questions

Gilead Sciences (GILD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation